Biggest News Aggregation in the World
📰 Jay Gladstein News

Jay Gladstein News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Jay Gladstein. Real-time updates on events, politics, business and more.

Enthusiasm for Once-Monthly Cabenuva Is High—But There Are Questions, Too

Enthusiasm for Once-Monthly Cabenuva Is High—But There Are Questions, Too The landmark U.S. Food and Drug Administration (FDA) approval of the first long-acting injectable HIV regimen, Cabenuva (cabotegravir/rilpivirine), in January burst open a new treatment door for many people living with HIV (PLWH). The approval signaled a move from daily pills to two shots in the butt—one for cabotegravir and the other for rilpivirine—once a month. You may be asking, though, will doctors now start sw...
University Of California San Francisco United States Los Angeles Katerina Christopoulos Jay Gladstein Christine Tran

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science